Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis-Reference-Cited by-同舟云学术

Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis

Published:2017-07-28 Issue:5 Volume:14 Page:552-563
ISSN:1541-2555
Container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease

Author:

Cazzola Mario¹^ORCID,Rogliani Paola¹^ORCID,Calzetta Luigino¹,Hanania Nicola A.²,Matera Maria Gabriella³^ORCID

Affiliation:

1. Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

2. Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, Texas, USA

3. Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15412555.2017.1347918

Reference58 articles.

1. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD – 2017. Available at: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/ (accessed April 6, 2017).

2. A review of national guidelines for management of COPD in Europe

3. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine: A Fresh Perspective;Journal of Clinical Medicine;2024-07-15

2. The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement;Current Research in Pharmacology and Drug Discovery;2024

3. Endoplasmic reticulum stress: a vital process and potential therapeutic target in chronic obstructive pulmonary disease;Inflammation Research;2023-09

4. Chronic Obstructive Pulmonary Disease Series Part 4: Identifying, Managing, and Preventing Exacerbations;The Senior Care Pharmacist;2023-09-01

5. Influence of dose and exposition time in the effectiveness of N-Acetyl-l-cysteine treatment in A549 human epithelial cells;Heliyon;2023-05